EquityZen Growth Technology Fund LLC - Series 549
Raised
$650K
Investors
37
Min Invest
$9,999
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 549 is a Delaware single-deal SPV filed by EquityZen Advisors LLC on 2020-04-21, raising $650K from 37 investors under Rule 506(b) and 3(c)(1) exemptions with a $10K minimum investment. This entity is part of the EquityZen platform, which operates nearly 1,900 pre-IPO secondary market vehicles enabling accredited investors to access private company shares.
This pre-IPO investment vehicle uses the standard 506(b)/3(c)(1) exemption structure common to EquityZen's platform, targeting retail accredited investors with a $10K minimum—typical for democratized secondary market access. The $17,568 average commitment across 37 investors reflects the platform's high-volume, small-check SPV model for fractionalized exposure to private growth companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
